Alteration of experimental cerebral vasospasm by adrenergic blockade.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000818:Animals; D001488:Basilar Artery / Q000187:drug effects; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004195:Disease Models, Animal; D006339:Heart Rate / Q000187:drug effects; D007275:Injections, Intravenous; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000209:etiology; D010643:Phenoxybenzamine / Q000008:administration & dosage / Q000627:therapeutic use*; D010646:Phentolamine / Q000008:administration & dosage / Q000627:therapeutic use*; D013345:Subarachnoid Hemorrhage / Q000150:complications
D000317:Adrenergic alpha-Antagonists; D010643:Phenoxybenzamine; D010646:Phentolamine